Literature DB >> 27744271

Surprising absence of heparin in the intestinal mucosa of baby pigs.

Yanlei Yu1,2, Yin Chen2, Paiyz Mikael2, Fuming Zhang2, Apryll M Stalcup3, Rebecca German4, Francois Gould4, Jocelyn Ohlemacher4, Hong Zhang1, Robert J Linhardt5.   

Abstract

Heparin, a member of a family of molecules called glycosaminoglycans, is biosynthesized in mucosal mast cells. This important anticoagulant polysaccharide is primarily produced by extraction of the mast cell-rich intestinal mucosa of hogs. There is concern about our continued ability to supply sufficient heparin to support the worldwide growth of advanced medical procedures from the static population of adult hogs used as food animals. While the intestinal mucosa of adult pigs is rich in anticoagulant heparin (containing a few hundred milligrams per animal), little is known about how the content of heparin changes with animal age. Using sophisticated mass spectral analysis we discovered that heparin was largely absent from the intestinal mucosa of piglets. Moreover, while the related, nonanticoagulant heparan sulfate glycosaminoglycan was present in significant amounts we found little chondroitin sulfate E also associated with mast cells. Histological evaluation of piglet intestinal mucosa showed a very low mast cell content. Respiratory mast cells have been reported in baby pigs suggesting that there was something unique about the piglets used in the current study. These piglets were raised in the relatively clean environment of a university animal facility and treated with antibiotics over their lifetime resulting in a depleted microbiome that greatly reduced the number of mast cells and heparin content of the intestinal mucosal in these animals. Thus, from the current study it remains unclear whether the lack of intestinal mast cell-derived heparin results from the young age of these animals or their exposure to their depleted microbiome.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotics; heparin; intestine; microbiome; pig

Mesh:

Substances:

Year:  2016        PMID: 27744271      PMCID: PMC5193109          DOI: 10.1093/glycob/cww104

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  29 in total

Review 1.  Order out of chaos: assembly of ligand binding sites in heparan sulfate.

Authors:  Jeffrey D Esko; Scott B Selleck
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 2.  Biosynthesis of heparin.

Authors:  U Lindahl
Journal:  Biochem Soc Trans       Date:  1990-10       Impact factor: 5.407

3.  Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells.

Authors:  R L Stevens; C C Fox; L M Lichtenstein; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 4.  Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.

Authors:  Rodger L Bick; Eugene P Frenkel; Jeanine Walenga; Jawed Fareed; Deborah A Hoppensteadt
Journal:  Hematol Oncol Clin North Am       Date:  2005-02       Impact factor: 3.722

Review 5.  Heparin and anticoagulation.

Authors:  Akihiro Onishi; Kalib St Ange; Jonathan S Dordick; Robert J Linhardt
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

6.  Processing of macromolecular heparin by heparanase.

Authors:  Feng Gong; Per Jemth; Martha L Escobar Galvis; Israel Vlodavsky; Alan Horner; Ulf Lindahl; Jin-ping Li
Journal:  J Biol Chem       Date:  2003-07-01       Impact factor: 5.157

7.  Role of glycosaminoglycans in cellular communication.

Authors:  Robert J Linhardt; Toshihiko Toida
Journal:  Acc Chem Res       Date:  2004-07       Impact factor: 22.384

8.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.

Authors:  R E Edens; A al-Hakim; J M Weiler; D G Rethwisch; J Fareed; R J Linhardt
Journal:  J Pharm Sci       Date:  1992-08       Impact factor: 3.534

9.  Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin.

Authors:  A A Horner
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

10.  Preparation and structural characterization of large heparin-derived oligosaccharides.

Authors:  A Pervin; C Gallo; K A Jandik; X J Han; R J Linhardt
Journal:  Glycobiology       Date:  1995-02       Impact factor: 4.313

View more
  3 in total

Review 1.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

2.  Structural characterization of a clinically described heparin-like substance in plasma causing bleeding.

Authors:  Yanlei Yu; Karen Bruzdoski; Vadim Kostousov; Lisa Hensch; Shiu-Ki Hui; Fakiha Siddiqui; Amber Farooqui; Ahmed Kouta; Fuming Zhang; Jawed Fareed; Jun Teruya; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2020-05-19       Impact factor: 9.381

3.  Metabolic engineering of Bacillus megaterium for heparosan biosynthesis using Pasteurella multocida heparosan synthase, PmHS2.

Authors:  Asher Williams; Kamil S Gedeon; Deepika Vaidyanathan; Yanlei Yu; Cynthia H Collins; Jonathan S Dordick; Robert J Linhardt; Mattheos A G Koffas
Journal:  Microb Cell Fact       Date:  2019-08-12       Impact factor: 5.328

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.